Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyDevoted Health Category III CPT Coverage | OpenPay…
    Ask Trek AI about this page
    ModifiedDevoted HealthPolicy MM.81

    Category III CPT Codes

    Customize your policy alerts

    Sign up for devoted_health Policy MM.81 alerts

    Get alerted when Policy MM.81 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of specific Category III CPT codes for all Devoted Health plans. Listed codes are considered experimental and unproven and are generally not covered; the list may not be all-inclusive.

    Policy Summary
    PayerDevoted Health
    PolicyCategory III CPT Codes
    Policy CodePolicy MM.81
    Change TypeModified
    Effective DateJune 9, 2025
    Last ReviewJun 8, 2026
    Next Review DateJune 15, 2027
    Key ActionDo not submit claims for Category III CPT codes identified as experimental and unproven because they may be denied as not covered.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    Three codes were removed from the policy scope on November 10, 2025.

    Four new codes were added on April 13, 2026.

    One code was added and policy language was edited on May 11, 2026.

    New codes effective July 1, 2026 were added during the June 8, 2026 annual review.

    Fifty-nine new codes were added on August 10, 2026.

    Code 0054T was added on September 14, 2026.

    Codes 1054T, 1056T, 1057T, 1064T-1070T, 1073T-1076T, 1078T-1081T, 1083T-1084T, 1087T-1089T, and 1091T-1111T were added effective October 1, 2026.

    All plansPlan applicability
    UnprovenCoverage classification
    Not all-inclusiveCode list scope
    Category IIICode category
    59Codes added Aug. 2026

    Experimental and Unproven Services

    Experimental and Unproven Services

    The following Category III CPT codes are considered experimental and unproven and are not covered.

    Listed Category III code: The billed service is one of the Category III CPT codes identified in this policy as experimental and unproven.

    The policy states that these services are unproven and not covered.

    Category III CPT codes designated experimental and unproven are not covered. The policy list may not be all-inclusive, so providers should verify the applicable code and coverage status before billing.

    Procedures identified in this policy as unproven are not covered. This applies to the listed services regardless of the clinical specialty or procedure type.

    Category III CPT Code List

    Experimental and Unproven Category III CPT CodesCPTExperimental
    0201TPercutaneous sacral augmentation (sacroplasty), bilateral injections, including the use of a balloon or mechanical device, when used, 2 or more needles, includes imaging guidance and bone biopsy, when performed.
    0278TTranscutaneous electrical modulation pain reprocessing (e.g., scrambler therapy), each treatment session (includes placement of electrodes).
    0342TTherapeutic apheresis with selective HDL delipidation and plasma reinfusion.
    0422TTactile breast imaging by computer-aided tactile sensors, unilateral or bilateral.
    0512TExtracorporeal shock wave for integumentary wound healing, including topical application and dressing care; initial wound.
    0604TOptical coherence tomography (OCT) of retina, remote, patient-initiated image capture and transmission to a remote surveillance center, unilateral or bilateral; initial device provision, set-up and patient education on use of equipment.
    0605TOptical coherence tomography (OCT) of retina, remote, patient-initiated image capture and transmission to a remote surveillance center, unilateral or bilateral; review, interpretation and report by the prescribing physician or other qualified health care professional of remote surveillance center data analyses, each.
    0606TRemote monitoring of an external continuous pulmonary fluid monitoring system, including measurement of radiofrequency-derived pulmonary fluid levels, heart rate, respiration rate, activity, posture, and cardiovascular rhythm.
    0636TComputed tomography, breast, including 3D rendering, when performed, bilateral; without contrast material(s).
    0637TComputed tomography, breast, including 3D rendering, when performed, bilateral; with contrast material(s).
    1–10 of 29
    1/3
    Identifiable Category III CPT CodesCPTNot Covered
    0902TAlgorithmic analysis of input from an external, patient-activated mobile ECG device
    0999TAutologous muscle cell therapy, administration of muscle progenitor cells into the urethral sphincter, including cystoscopy and post-void residual ultrasound, when performed
    1029TMapping and programming of neurostimulation catheter with delivery of transvenous phrenic neurostimulation therapy in ventilated patients, without catheter repositioning, per session
    1041TAugmentative algorithmic analysis of encephalographic waveforms to identify the source and propagation of epileptiform activity, including artifact reduction, 3D localization and interpretation and report related to a previously performed EEG
    1042TQuantitative magnetic resonance, without imaging, for analysis of liver tissue, including assessment of one or more parameters, with automatically generated report
    1044THarvest of full-thickness skin for autologous heterogeneous skin-construct graft, including direct closure of donor site; each additional 5 cm
    1060TElectronic analysis of implanted subcutaneous supraorbital-occipital neurostimulator pulse generator with complex programming by a physician or other qualified health care professional
    1061TArtificial insemination, transcervical intratubal, unilateral or bilateral, including
    1062TOncology (bladder), augmentative algorithmic analysis of histomorphologic features in digitized slides from FFPE bladder cancer tissue, with algorithm-derived parameters reported as prognostic of recurrence and progression
    1091TImplantation of acellular scaffold, such as hyaluronan, into a chondral or osteochondral defect of the knee, arthroscopic
    1–10 of 17
    1/2
    Category III CPT codes added or identified in the version historyCPT
    0054T
    1054T
    1056T
    1057T
    1064T
    1065T
    1066T
    1067T
    1068T
    1069T
    1–10 of 43
    1/5
    Minor bladder lesion
    CategoryMinor bladder lesion
    ThresholdTotal lesion diameter less than 0.5 cm
    Coverage statusUnproven; not covered
    Small bladder lesion
    CategorySmall bladder lesion
    ThresholdTotal lesion diameter greater than or equal to 0.5 cm and less than 2.0 cm
    Coverage statusUnproven; not covered
    Medium bladder lesion
    CategoryMedium bladder lesion
    ThresholdTotal lesion diameter greater than or equal to 2.0 cm and less than 5.0 cm
    Coverage statusUnproven; not covered
    Large bladder lesion
    CategoryLarge bladder lesion
    ThresholdTotal lesion diameter greater than or equal to 5.0 cm
    Coverage statusUnproven; not covered
    Residual stone fragment
    CategoryResidual stone fragment
    ThresholdLess than or equal to 5 mm
    Coverage statusUnproven; not covered
    Prostate volume
    MeasurementProstate volume
    ThresholdGreater than or equal to 50 mL
    Coverage statusUnproven; not covered

    Claims and Denial Considerations

    Denial Risk

    Experimental or Unproven Category III Codes

    Claims for Category III CPT codes identified as experimental and unproven may be denied as not covered. The list may not be all inclusive.

    Denial Risk

    Unproven Category III Procedures

    Claims for the Category III procedures identified as unproven and not covered are subject to denial because the policy does not provide coverage for them. Identified codes include 0902T, 0999T, 1029T, 1041T, 1042T, 1044T, 1060T–1062T, 1091T, 1097T, 1098T, 1100T, 1101T, 1104T, and 1107T–1108T.

    Policy Context

    The policy addresses emerging and investigational services across multiple domains, including pathology and digital slide analysis, neuromodulation, oncology, transplantation, cardiovascular monitoring, urology, ophthalmology, and musculoskeletal care. These services are generally classified as unproven and not covered, rather than covered subject to clinical-necessity criteria.

    Terms and Acronyms

    Experimental and unproven
    TermExperimental and unproven
    DefinitionCategory III CPT codes listed in this policy are considered experimental and unproven for coverage purposes.
    Coverage implicationCategory III CPT codes designated as experimental and unproven are not covered.
    CPT
    AbbreviationCPT
    MeaningCurrent Procedural Terminology
    Policy useThe policy addresses Category III CPT codes.
    Policy Summary
    PayerDevoted Health
    PolicyCategory III CPT Codes
    Policy CodePolicy MM.81
    Change TypeModified
    Effective DateJune 9, 2025
    Last ReviewJun 8, 2026
    Next Review DateJune 15, 2027
    Key ActionDo not submit claims for Category III CPT codes identified as experimental and unproven because they may be denied as not covered.
    SourceLink
    On This Page
    Experimental and Unproven ServicesCategory III CPT Code ListClaims and Denial ConsiderationsPolicy ContextTerms and Acronyms
    CMS
    AbbreviationCMS
    MeaningCenters for Medicare and Medicaid Services
    Definition sourceListed in the policy's Acronyms and Definitions section.
    LCD
    AbbreviationLCD
    MeaningLocal Coverage Determinations
    Definition sourceListed in the policy's Acronyms and Definitions section.
    MCD
    AbbreviationMCD
    MeaningCMS Medicare Coverage Database
    Definition sourceListed in the policy's Acronyms and Definitions section.
    NCD
    AbbreviationNCD
    MeaningNational Coverage Determination
    Definition sourceListed in the policy's Acronyms and Definitions section.
    UM
    AbbreviationUM
    MeaningUtilization Management
    Definition sourceListed in the policy's Acronyms and Definitions section.